scholarly journals Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials

2013 ◽  
Vol 14 (1) ◽  
Author(s):  
Joseph L Micca ◽  
Dustin Ruff ◽  
Jonna Ahl ◽  
Madelaine M Wohlreich
2018 ◽  
Vol 23 (6) ◽  
pp. 1019-1026 ◽  
Author(s):  
Hiroyuki Enomoto ◽  
Shinji Fujikoshi ◽  
Toshinaga Tsuji ◽  
Nao Sasaki ◽  
Hirofumi Tokuoka ◽  
...  

2014 ◽  
Vol 36 (4) ◽  
pp. 544-551 ◽  
Author(s):  
Owen D. Williamson ◽  
Melissa Schroer ◽  
Dustin D. Ruff ◽  
Jonna Ahl ◽  
Anthony Margherita ◽  
...  

2019 ◽  
Vol 27 ◽  
pp. S499
Author(s):  
R.M. Stevens ◽  
J.N. Campbell ◽  
K. Guedes ◽  
V.H. Smith ◽  
P.D. Hanson ◽  
...  

Cancers ◽  
2019 ◽  
Vol 11 (4) ◽  
pp. 578 ◽  
Author(s):  
Gerardo Rosati ◽  
Stefano Cordio ◽  
Giorgio Reggiardo ◽  
Giuseppe Aprile ◽  
Alfredo Butera ◽  
...  

Patients older than 75 years of age are usually excluded from metastatic colorectal cancer studies based on a combination chemotherapy containing oxaliplatin. Our group conducted three phase II trials in elderly patients in recent years. A post-hoc subgroup analysis of 67 patients aged at least 75 years was included in this study. Oxaliplatin was combined with capecitabine in two trials and with uracil-tegafur (UFT) plus folinic acid in the third trial. In one study, bevacizumab was also added to chemotherapy. The median age of patients was 77 years, and all had a good performance status (0 to 1). The observed overall response rate was 45%, comparable to younger patients (51%, p = 0.49). The estimated median progression-free survival (PFS) time and overall survival (OS) time were 8.7 and 19.3 months, respectively. These results did not significantly differ from those in younger patients (8.0 months for PFS (p = 0.58) and 19.7 months for OS (p = 0.94), respectively). The most common grade 3–4 adverse events included diarrhea (13%), fatigue (13%), peripheral neuropathy (10%), and neutropenia (7%). Moreover, the toxicity was never statistically different from that in younger patients. The efficacy of oxaliplatin-based combination was maintained in fit elderly patients ≥75 years.


2012 ◽  
Vol 30 (3) ◽  
pp. 187-194 ◽  
Author(s):  
Nithima Purepong ◽  
Anusorn Jitvimonrat ◽  
Ekalak Sitthipornvorakul ◽  
Sukanya Eksakulkla ◽  
Prawit Janwantanakul

Objectives To assess two aspects of the external validity of acupuncture research for osteoarthritis knee pain and determine the common acupoints and treatment parameters used. Methods The external validity of 16 randomised controlled trials (RCTs) was investigated using a scale consisting of two aspects: reporting and performance. The reporting aspect included acupuncturist's background, study location, treatment detailed, patient characteristics, positive trial results, adverse effects and between-group statistical differences, whereas treatment appropriateness, appropriate controls and outcomes were classified as the performance aspect. Acupuncture treatment in RCTs was compared with common practice according to the literature sources and survey of acupuncturists working in different parts of Thailand. Results The levels of external validity for the reporting and performance aspects were in the range of 31.3% to 100%. Statistic values such as mean difference and confidence interval were reported by the minority of trials (43.8%). Patient satisfaction and quality of life were seldom used (31.3%). There were minor differences between research and practice in terms of the points used (25.0%), number of treatment sessions (6.3%) and frequency (12.5%). The most frequently used points were ST34, ST35, ST36, SP6, SP9, SP10, GB34, Xiyan and ah shi points, and the commonly used treatment parameters were 20 minutes, 10–15 sessions and two treatments weekly. Conclusions Reporting of the external validity of acupuncture RCTs for knee pain was notably inadequate in terms of trial setting, treatment provider and statistical reporting. The majority of studies involved appropriate controls and outcomes and applied acupuncture treatments in line with practice.


Pain Medicine ◽  
2015 ◽  
Vol 16 (7) ◽  
pp. 1373-1385 ◽  
Author(s):  
Zhao Yu Wang ◽  
Sheng Ying Shi ◽  
Shu Jie Li ◽  
Feng Chen ◽  
Huang Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document